Abbott, Reckitt Fall

Reckitt’s Mead Johnson, Abbott to face new trial in US infant-formula case
Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over allegations their premature infant formula can cause a serious gut condition. In October,
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Reckitt still assessing options for Mead Johnson infant-formula “exit”
CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing Mead Johnson.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for injuries suffered by a child who consumed its formula designed for premature babies.
Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
As trade war intensifies, Reckitt may be more exposed than some rivals
Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...
Devdiscourse4h
Reckitt's Tariff Troubles: Navigating the U.S. Trade Storm
Reckitt faces potential tariff issues in the U.S. due to its manufacturing reliance on imports from Mexico and Southeast Asia ...
Reckitt announces redundancy proposals as part of 'structural changes'
Reckitt has announced redundancy proposals as part of "proposed structural changes" within the organisation.
Lysol Maker Reckitt Benckiser Shares Rise After Profit Beat
Adjusted profit of nearly £3.5 billion came in ahead of expectations for 2024 as the consumer-goods company continues to ...
Investing.com India3d
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...
Reckitt Benckiser downgraded to Neutral from Buy at BofA
BofA downgraded Reckitt Benckiser (RBGLY) to Neutral from Buy citing a lack of near-term catalysts and its preference for Unilever. Optimize ...